185
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Breaking Down Cachexia: A Narrative Review on the Prevalence of Cachexia in Cancer Patients and Its Associated Risk Factors

, &
Pages 404-418 | Received 20 Oct 2023, Accepted 16 Feb 2024, Published online: 28 Mar 2024

References

  • Nishie K, Nishie T, Sato S, Hanaoka M. Update on the treatment of cancer cachexia. Drug Discov Today. 2023;28(9):103689. doi:10.1016/j.drudis.2023.103689
  • Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, et al. Cachexia: a new definition. Clin Nutr. 2008;27(6):793–9. doi:10.1016/j.clnu.2008.06.013
  • Yoshida T, Delafontaine P. Mechanisms of cachexia in chronic disease states. Am J Med Sci. 2015;350(4):250–6. doi: 10.1097/MAJ.0000000000000511
  • Scherbakov N, Doehner W. Cachexia as a common characteristic in multiple chronic disease. J Cachexia Sarcopenia Muscle. 2018;9(7):1189–91. doi:10.1002/jcsm.12388
  • Hanaoka BY, Zhao J, Heitman K, Khan F, Jarjour W, Volek J, Brock G, Gower BA. Interaction effect of systemic inflammation and modifiable rheumatoid cachexia risk factors on resting energy expenditure in patients with rheumatoid arthritis. JCSM Clin Rep. 2022;7(1):12–23. doi:10.1002/crt2.45
  • Malla J, Zahra A, Venugopal S, Selvamani TY, Shoukrie SI, Selvaraj R, Dhanoa RK, Hamouda RK, Mostafa J. What role do inflammatory cytokines play in cancer cachexia? Cureus. 2022;14(7):e26798. doi:10.7759/cureus.26798
  • Yeom E, Yu K. Understanding the molecular basis of anorexia and tissue wasting in cancer cachexia. Exp Mol Med. 2022;54(4):426–32. doi:10.1038/s12276-022-00752-w
  • Beutler B, Greenwald D, Hulmes J, Chang M, Pan Y-C, Mathison J, Ulevitch R, Cerami A. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature. 1985;316(6028):552–4. doi:10.1038/316552a0
  • Beutler B, Mahoney J, Le Trang N, Pekala P, Cerami A. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med. 1985;161(5):984–95. doi:10.1084/jem.161.5.984
  • Mangano GD, Fouani M, D’Amico D, Di Felice V, Barone R. Cancer-related cachexia: the vicious circle between inflammatory cytokines, skeletal muscle, lipid metabolism and the possible role of physical training. Int J Mol Sci. 2022;23(6):3004. doi:10.3390/ijms23063004
  • Ahmad SS, Ahmad K, Shaikh S, You HJ, Lee E-Y, Ali S, Lee EJ, Choi I. Molecular mechanisms and current treatment options for cancer cachexia. Cancers (Basel). 2022;14(9):2107. doi:10.3390/cancers14092107
  • Marcora SM, Chester KR, Mittal G, Lemmey AB, Maddison PJ. Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis2. Am J Clin Nutr. 2006;84(6):1463–72. doi:10.1093/ajcn/84.6.1463
  • Jatoi A, Dakhil SR, Nguyen PL, Sloan JA, Kugler JW, Rowland KM, Soori GS, Wender DB, Fitch TR, Novotny PJ, et al. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group. Cancer. 2007;110(6):1396–403. doi:10.1002/cncr.22944
  • Miller A, McLeod L, Alhayyani S, Szczepny A, Watkins D, Chen W, Enriori P, Ferlin W, Ruwanpura S, Jenkins B. Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma. Oncogene. 2017;36(21):3059–66. doi:10.1038/onc.2016.437
  • Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KC. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4(1):17105. doi:10.1038/nrdp.2017.105
  • Costamagna D, Duelen R, Penna F, Neumann D, Costelli P, Sampaolesi M. Interleukin-4 administration improves muscle function, adult myogenesis, and lifespan of colon carcinoma-bearing mice. J Cachexia Sarcopenia Muscle. 2020;11(3):783–801. doi:10.1002/jcsm.12539
  • Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–95. doi:10.1016/S1470-2045(10)70218-7
  • Gong C, Wan Q, Zhao R, Zuo X, Chen Y, Li T. Cachexia index as a prognostic indicator in patients with gastric cancer: a retrospective study. Cancers. 2022;14(18):4400. doi:10.3390/cancers14184400
  • Von Haehling S, Anker MS, Anker SD. Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016. J Cachexia Sarcopenia Muscle. 2016;7(5):507–. doi:10.1002/jcsm.12167
  • Shukuya T, Takahashi K, Shintani Y, Miura K, Sekine I, Takayama K, Inoue A, Okamoto I, Kiura K, Kawaguchi T, et al. Epidemiology, risk factors and impact of cachexia on patient outcome: results from the Japanese Lung Cancer Registry Study. J Cachexia Sarcopenia Muscle. 2023;14(3):1274–85. doi:10.1002/jcsm.13216
  • Di Girolamo D, Tajbakhsh S. Pathological features of tissues and cell populations during cancer cachexia. Cell Regen. 2022;11(1):15. doi:10.1186/s13619-022-00108-9
  • Siddiqui JA, Pothuraju R, Jain M, Batra SK, Nasser MW. Advances in cancer cachexia: intersection between affected organs, mediators, and pharmacological interventions. Biochim Biophys Acta Rev Cancer. 2020;1873(2):188359. doi:10.1016/j.bbcan.2020.188359
  • Oakvik J, Ready D. Updates in cancer-related symptom management of anorexia and cachexia syndrome. Semin Oncol Nurs. 2022;38(1):151254. doi:10.1016/j.soncn.2022.151254
  • Johal J, Han CY, Joseph R, Munn Z, Agbejule OA, Crawford-Williams F, Wallen MP, Chan RJ, Hart NH. Dietary supplements in people with metastatic cancer who are experiencing malnutrition, cachexia, sarcopenia, and frailty: a scoping review. Nutrients. 2022;14(13):2642. doi:10.3390/nu14132642
  • Argilés JM, López-Soriano FJ, Stemmler B, Busquets S. Cancer-associated cachexia—Understanding the tumour macroenvironment and microenvironment to improve management. Nat Rev Clin Oncol. 2023;20(4):250–64. doi:10.1038/s41571-023-00734-5
  • Baethge C, Goldbeck-Wood S, Mertens S. SANRA—a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4(1):5. doi:10.1186/s41073-019-0064-8
  • Di Meglio A, Michiels S, Jones LW, El-Mouhebb M, Ferreira AR, Martin E, Matias M, Lohmann AE, Joly F, Vanlemmens L, et al. Changes in weight, physical and psychosocial patient-reported outcomes among obese women receiving treatment for early-stage breast cancer: a nationwide clinical study. The Breast. 2020;52:23–32. doi:10.1016/j.breast.2020.04.002
  • Griffin OM, Duggan SN, Ryan R, McDermott R, Geoghegan J, Conlon KC. Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer. Pancreatology. 2019;19(6):850–7. doi:10.1016/j.pan.2019.07.039
  • Kiss N, Isenring E, Gough K, Krishnasamy M. The prevalence of weight loss during (chemo)radiotherapy treatment for lung cancer and associated patient- and treatment-related factors. Clin Nutr. 2014;33(6):1074–80. doi:10.1016/j.clnu.2013.11.013
  • van der Meij BS, Schoonbeek CP, Smit EF, Muscaritoli M, van Leeuwen PA, Langius JA. Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks. Br J Nutr. 2013;109(12):2231–9. doi:10.1017/S0007114512004527
  • Jager-Wittenaar H, Dijkstra PU, Dijkstra G, Bijzet J, Langendijk JA, van der Laan BF, Roodenburg JL. High prevalence of cachexia in newly diagnosed head and neck cancer patients: an exploratory study. Nutrition. 2017;35:114–8. doi:10.1016/j.nut.2016.11.008
  • Liao WC, Chen PR, Huang CC, Chang YT, Huang BS, Chang CC, Wu MS, Chow LP. Relationship between pancreatic cancer-associated diabetes and cachexia. J Cachexia Sarcopenia Muscle. 2020;11(4):899–908. doi:10.1002/jcsm.12553
  • Dijksterhuis WPM, Latenstein AEJ, van Kleef JJ, Verhoeven RHA, de Vries JHM, Slingerland M, Steenhagen E, Heisterkamp J, Timmermans LM, de van der Schueren MAE, et al. Cachexia and dietetic interventions in patients with esophagogastric cancer: a multicenter cohort study. J Natl Compr Canc Netw. 2021;19(2):144–52. doi:10.6004/jnccn.2020.7615
  • Poisson J, Martinez-Tapia C, Heitz D, Geiss R, Albrand G, Falandry C, Gisselbrecht M, Couderc A, Boulahssass R, Liuu E, et al. Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer). J Cachexia Sarcopenia Muscle. 2021;12(6):1477–88. doi:10.1002/jcsm.12776
  • Morimoto K, Uchino J, Yokoi T, Kijima T, Goto Y, Nakao A, Hibino M, Takeda T, Yamaguchi H, Takumi C, et al. Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study. Oncoimmunology. 2021;10(1):1950411. doi:10.1080/2162402X.2021.1950411
  • Bachmann J, Büchler MW, Friess H, Martignoni ME. Cachexia in patients with chronic pancreatitis and pancreatic cancer: impact on survival and outcome. Nutr Cancer. 2013;65(6):827–33. doi:10.1080/01635581.2013.804580
  • Lan X, Robin G, Kasnik J, Wong G, Abdel-Rahman O. Challenges in diagnosis and treatment of pancreatic exocrine insufficiency among patients with pancreatic ductal adenocarcinoma. Cancers. 2023;15(4):1331. doi:10.3390/cancers15041331
  • Rini FS, Murbawani EA, Fasitasari M, Puruhita N. The relationship between nutritional status before chemotherapy with nutritional status after chemotherapy in locoregionally advanced nasopharyngeal carcinoma patients. Bali Med J. 2023;12(1):845–50.
  • Lu S-W, Pan H-C, Hsu Y-H, Chang K-C, Wu L-W, Chen W-Y, Chang M-S. IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models. Nat Commun. 2020;11(1):4611. doi:10.1038/s41467-020-18244-8
  • Suriben R, Chen M, Higbee J, Oeffinger J, Ventura R, Li B, Mondal K, Gao Z, Ayupova D, Taskar P, et al. Antibody-mediated inhibition of GDF15–GFRAL activity reverses cancer cachexia in mice. Nat Med. 2020;26(8):1264–70. doi:10.1038/s41591-020-0945-x
  • Braun TP, Zhu X, Szumowski M, Scott GD, Grossberg AJ, Levasseur PR, Graham K, Khan S, Damaraju S, Colmers WF, et al. Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic–pituitary–adrenal axis. J Exp Med. 2011;208(12):2449–63. doi:10.1084/jem.20111020
  • Bilir C, Engin H, Can M, Temi YB, Demirtas D. The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia. Med Oncol. 2015;32(3):1–6. doi:10.1007/s12032-015-0497-y
  • Penafuerte CA, Gagnon B, Sirois J, Murphy J, MacDonald N, Tremblay ML. Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia. Br J Cancer. 2016;114(6):680–7. doi:10.1038/bjc.2016.3
  • Han J, Lu C, Meng Q, Halim A, Yean TJ, Wu G. Plasma concentration of interleukin-6 was upregulated in cancer cachexia patients and was positively correlated with plasma free fatty acid in female patients. Nutr Metab. 2019;16(1):80.
  • Grim-Stieger M, Keilani M, Mader R, Marosi C, Schmidinger M, Zielinski C, Fialka-moser V, Crevenna R. Serum levels of tumour necrosis factor-α and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate–preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapy. Eur J Cancer Care. 2008;17(5):454–62. doi:10.1111/j.1365-2354.2007.00874.x
  • Lerner L, Gyuris J, Nicoletti R, Gifford J, Krieger B, Jatoi A. Growth differentiating factor-15 (GDF-15): a potential biomarker and therapeutic target for cancer-associated weight loss. Oncol Lett. 2016;12(5):4219–23. doi:10.3892/ol.2016.5183
  • National Cancer Institute. Age and Cancer Risk. 2021. https://www.cancer.gov/about-cancer/causes-prevention/risk/age.
  • Li X, Hu C, Zhang Q, Wang K, Li W, Xu H, Fu Z, Wang C, Guo Z, Weng M. Cancer cachexia statistics in China. Precision Nutrition. 2022;1(1):10.1097.
  • Geppert J, Walth AA, Terrón Expósito R, Kaltenecker D, Morigny P, Machado J, Becker M, Simoes E, Lima JDCC, Daniel C, et al. Aging aggravates cachexia in tumor-bearing mice. Cancers. 2022;14(1):90. doi:10.3390/cancers14010090
  • Ali S, Garcia JM. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options-a mini-review. Gerontology. 2014;60(4):294–305. doi:10.1159/000356760
  • Tagliafico AS, Bignotti B, Torri L, Rossi F. Sarcopenia: how to measure, when and why. Radiol Med. 2022;127(3):228–37. doi:10.1007/s11547-022-01450-3
  • Dunne RF, Roussel B, Culakova E, Pandya C, Fleming FJ, Hensley B, Magnuson AM, Loh KP, Gilles M, Ramsdale E, et al. Characterizing cancer cachexia in the geriatric oncology population. J Geriatr Oncol. 2019;10(3):415–9. doi:10.1016/j.jgo.2018.08.008
  • Fostinelli S, De Amicis R, Leone A, Giustizieri V, Binetti G, Bertoli S, Battezzati A, Cappa SF. Eating behavior in aging and dementia: the need for a comprehensive assessment. Front Nutr. 2020;7:604488. doi:10.3389/fnut.2020.604488
  • Rasheedy D, EL-Kawaly WH. The cumulative impact of sarcopenia, frailty, malnutrition, and cachexia on other geriatric syndromes in hospitalized elderly. Electron J Gen Med. 2021;18(2):em277. doi:10.29333/ejgm/9695
  • Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15(9):505–22. doi:10.1038/s41569-018-0064-2
  • Ward EM, Sherman RL, Henley SJ, Jemal A, Siegel DA, Feuer EJ, Firth AU, Kohler BA, Scott S, Ma J, et al. Annual report to the nation on the status of cancer, featuring cancer in men and women age 20–49 years. J Natl Cancer Inst. 2019;111(12):1279–97. doi:10.1093/jnci/djz106
  • Lopes-Ramos CM, Quackenbush J, DeMeo DL. Genome-wide sex and gender differences in cancer. Front Oncol. 2020;10:597788. doi:10.3389/fonc.2020.597788
  • Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. doi:10.3322/caac.21763
  • National Cancer Institute. Cancer Statistics. 2020. https://www.cancer.gov/about-cancer/understanding/statistics.
  • Yoon SL, Grundmann O, Williams JJ, Gordan L, George TJ. Body composition changes differ by gender in stomach, colorectal, and biliary cancer patients with cachexia: results from a pilot study. Cancer Med. 2018;7(8):3695–703. doi:10.1002/cam4.1665
  • Haizlip KM, Harrison BC, Leinwand LA. Sex-based differences in skeletal muscle kinetics and fiber-type composition. Physiology. 2015;30(1):30–9. doi:10.1152/physiol.00024.2014
  • Plotkin DL, Roberts MD, Haun CT, Schoenfeld BJ. Muscle fiber type transitions with exercise training: shifting perspectives. Sports. 2021;9(9):127. doi:10.3390/sports9090127
  • Zhong X, Zimmers TA. Sex differences in cancer cachexia. Curr Osteoporos Rep. 2020;18(6):646–54. doi:10.1007/s11914-020-00628-w
  • Johns N, Hatakeyama S, Stephens NA, Degen M, Degen S, Frieauff W, Lambert C, Ross JA, Roubenoff R, Glass DJ, et al. Clinical classification of cancer cachexia: phenotypic correlates in human skeletal muscle. PLOS One. 2014;9(1):e83618. doi:10.1371/journal.pone.0083618
  • Huot JR, Baumfalk D, Resendiz A, Bonetto A, Smuder AJ, Penna F. Targeting mitochondria and oxidative stress in cancer-and chemotherapy-induced muscle wasting. Antioxid Redox Signal. 2023;38(4-6):352–70. doi:10.1089/ars.2022.0149
  • Cardinale DA, Larsen FJ, Schiffer TA, Morales-Alamo D, Ekblom B, Calbet JAL, Holmberg HC, Boushel R. Superior intrinsic mitochondrial respiration in women than in men. Front Physiol. 2018;9:1133. doi:10.3389/fphys.2018.01133
  • Miotto PM, McGlory C, Holloway TM, Phillips SM, Holloway GP. Sex differences in mitochondrial respiratory function in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2018;314(6):R909–R915. doi:10.1152/ajpregu.00025.2018
  • Lindholm ME, Marabita F, Gomez-Cabrero D, Rundqvist H, Ekström TJ, Tegnér J, Sundberg CJ. An integrative analysis reveals coordinated reprogramming of the epigenome and the transcriptome in human skeletal muscle after training. Epigenetics. 2014;9(12):1557–69. doi:10.4161/15592294.2014.982445
  • Morton M, Patterson J, Sciuva J, Perni J, Backes F, Nagel C, O’Malley DM, Chambers LM. Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer. Gynecol Oncol. 2023;175:142–55. doi:10.1016/j.ygyno.2023.06.015
  • Muscaritoli M, Lucia S, Farcomeni A, Lorusso V, Saracino V, Barone C, Plastino F, Gori S, Magarotto R, Carteni G, et al. Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study. Oncotarget. 2017;8(45):79884–96. doi:10.18632/oncotarget.20168
  • Vagnildhaug OM, Balstad TR, Almberg SS, Brunelli C, Knudsen AK, Kaasa S, Thronæs M, Laird B, Solheim TS. A cross-sectional study examining the prevalence of cachexia and areas of unmet need in patients with cancer. Support Care Cancer. 2018;26(6):1871–80. doi:10.1007/s00520-017-4022-z
  • McPhail S, Johnson S, Greenberg D, Peake M, Rous B. Stage at diagnosis and early mortality from cancer in England. Br J Cancer. 2015;112(Suppl 1):S108–S115. doi:10.1038/bjc.2015.49
  • Dong Q, Liu X, Cheng K, Sheng J, Kong J, Liu T. Pre-metastatic niche formation in different organs induced by tumor extracellular vesicles. Front Cell Dev Biol. 2021;9:733627. doi:10.3389/fcell.2021.733627
  • Wang G, Biswas AK, Ma W, Kandpal M, Coker C, Grandgenett PM, Hollingsworth MA, Jain R, Tanji K, Lόpez-Pintado S, et al. Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. Nat Med. 2018;24(6):770–81. doi:10.1038/s41591-018-0054-2
  • Nourissat A, Mille D, Delaroche G, Jacquin JP, Vergnon JM, Fournel P, Seffert P, Porcheron J, Michaud P, Merrouche Y, et al. Estimation of the risk for nutritional state degradation in patients with cancer: development of a screening tool based on results from a cross-sectional survey. Ann Oncol. 2007;18(11):1882–6. doi:10.1093/annonc/mdm355
  • Fukahori M, Shibata M, Hamauchi S, Kasamatsu E, Machii K. A retrospective cohort study to investigate the incidence of cancer-related weight loss during chemotherapy in gastric cancer patients. Support Care Cancer. 2021;29(1):341–8. doi:10.1007/s00520-020-05479-w
  • Shibata M, Fukahori M, Kasamatsu E, Machii K, Hamauchi S. A retrospective cohort study to investigate the incidence of cachexia during chemotherapy in patients with colorectal cancer. Adv Ther. 2020;37(12):5010–22. doi:10.1007/s12325-020-01516-6
  • Amano K, Baracos VE, Morita T, Miura T, Mori N, Tatara R, Kessoku T, Tokoro A, Tagami K, Otani H, et al. The impact of cachexia on dietary intakes, symptoms, and quality of life in advanced cancer. JCSM Rapid Commun. 2022;5(2):162–70. doi:10.1002/rco2.61
  • Domingo IK, Latif A, Bhavsar AP. Pro-inflammatory signalling PRRopels cisplatin-induced toxicity. Int J Mol Sci. 2022;23(13):7227. doi:10.3390/ijms23137227
  • Yamanobe H, Yamamoto K, Kishimoto S, Nakai K, Oseko F, Yamamoto T, Mazda O, Kanamura N. Anti-inflammatory effects of β-cryptoxanthin on 5-fluorouracil-induced cytokine expression in human oral mucosal keratinocytes. Molecules. 2023;28(7):2935. doi:10.3390/molecules28072935
  • Shi S, Chen Y, Luo Z, Nie G, Dai Y. Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy. Cell Commun Signal. 2023;21(1):1–20. doi:10.1186/s12964-023-01077-5
  • Masi T, Patel BM. Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison. Pharmacol Rep. 2021;73(1):17–30. doi:10.1007/s43440-020-00179-y
  • Yoon JW, Ha YC, Kim KM, Moon JH, Choi SH, Lim S, Park YJ, Lim JY, Kim KW, Park KS, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean Longitudinal Study on Health and Aging. Diabetes Metab J. 2016;40(2):140–6. doi:10.4093/dmj.2016.40.2.140
  • Mori H, Kuroda A, Araki M, Suzuki R, Taniguchi S, Tamaki M, Akehi Y, Matsuhisa M. Advanced glycation end-products are a risk for muscle weakness in Japanese patients with type 1 diabetes. J Diabetes Investig. 2017;8(3):377–82. doi:10.1111/jdi.12582
  • Dhindsa S, Ghanim H, Green K, Abuaysheh S, Batra M, Makdissi A, Chaudhuri A, Sandhu S, Dandona P. Acute effects of insulin on skeletal muscle growth and differentiation genes in men with type 2 diabetes. Eur J Endocrinol. 2019;181(6):K55–K59. doi:10.1530/EJE-19-0514
  • Lundholm K, Körner U, Gunnebo L, Sixt-Ammilon P, Fouladiun M, Daneryd P, Bosaeus I. Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning. Clin Cancer Res. 2007;13(9):2699–706. doi:10.1158/1078-0432.CCR-06-2720
  • Hirata Y, Nomura K, Senga Y, Okada Y, Kobayashi K, Okamoto S, Minokoshi Y, Imamura M, Takeda S, Hosooka T, et al. Hyperglycemia induces skeletal muscle atrophy via a WWP1/KLF15 axis. JCI Insight. 2019;4(4):e124952. doi:10.1172/jci.insight.124952
  • Franceschini JP, Jamnik S, Santoro IL. Role that anorexia and weight loss play in patients with stage IV lung cancer. J Bras Pneumol. 2020;46(1):e20190420. doi:10.1590/1806-3713/e20190412
  • Kaaks R, Johnson T, Tikk K, Sookthai D, Tjønneland A, Roswall N, Overvad K, Clavel-Chapelon F, Boutron-Ruault M-C, Dossus L, et al. Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status—A prospective study within the EPIC cohort. Int J Cancer. 2014;134(11):2683–90. doi:10.1002/ijc.28589
  • Martín AI, Priego T, Moreno-Ruperez Á, González-Hedström D, Granado M, López-Calderón A. IGF-1 and IGFBP-3 in inflammatory cachexia. Int J Mol Sci. 2021;22(17):9469. doi:10.3390/ijms22179469

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.